alexa osteosarcoma | Mexico| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


  • osteosarcoma

    Osteosarcoma is an essential harmful tumor of the skeleton portrayed by the immediate arrangement of youthful bone or osteoid tissue by the tumor cells. The fantastic osteosarcoma is an uncommon (0.2% of every dangerous tumor) exceedingly harmful tumor, with an expected rate of 3 cases/million populace/year. Osteosarcoma emerges overwhelmingly in the long bones and once in a while in the delicate tissues.In around 75% of cases, patients with osteosarcoma are between 15–25 years old. Male are more regularly influenced than female (proportion 1.5:1). Osteosarcoma seldom happens in patients more youthful than 6 years or more established than 60 years.

  • osteosarcoma

    Tumors saw in more established age more often than not create optional to Paget's sickness, radiation or dedifferentiated chondrosarcomas. Medications utilized as a part of treatment of osteosarcoma are high-measurements Methotrexate (HDMTX), Cisplatin (CDP), Adriamycin (ADM) and Ifosfamide (IF), for the most part utilized as a part of blend. It is not clear if a 4-drugs mix (HDMTX, CDP, ADM, IF) offers focal points over a 3-drugs mix (HDTX, CDP, DM) treatment. In a few focuses, ADM and CDP are conveyed intra-arteriall

High Impact List of Articles

Conference Proceedings